日本新薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2018/10/12日証協無担保400株-98.69%300株0%12,902株+9.79%
2018/10/12日証協有担保231,980株-18.39%3,600株-53.57%102,360株-5.86%
2018/10/05日証協無担保30,600株+509.08%0株0%11,752株-72.82%
2018/10/05日証協有担保284,249株+91.37%7,753株+158.43%108,726株+8.48%
2018/09/28日証協無担保5,024株0%0株-100%43,236株+9999.99%
2018/09/28日証協有担保148,535株+9.09%3,000株-91.64%100,224株+1201.61%
2018/09/21日証協無担保0株0%12,176株+2335.2%70株-82.5%
2018/09/21日証協有担保136,160株-9.49%35,900株-50.62%7,700株-54.9%
2018/09/14日証協無担保0株-100%500株-76.46%400株+296.04%
2018/09/14日証協有担保150,443株-23.87%72,700株+673.4%17,074株-81.4%
2018/09/07日証協無担保2,300株-74.73%2,124株+324.8%101株-79.8%
2018/09/07日証協有担保197,621株+139.86%9,400株+9300%91,800株+260%
2018/08/31日証協無担保9,100株0%500株-85.4%500株-2.15%
2018/08/31日証協有担保82,390株-0.05%100株-50%25,500株+27.5%
2018/08/24日証協無担保0株-100%3,424株0%511株+27.75%
2018/08/24日証協有担保82,430株-0.35%200株-98.77%20,000株+135.29%
2018/08/17日証協無担保3,200株0%0株0%400株-73.33%
2018/08/17日証協有担保82,722株-16.71%16,200株+8000%8,500株-2.3%
2018/08/10日証協無担保0株0%0株0%1,500株+66.67%
2018/08/10日証協有担保99,321株-47.71%200株-99.23%8,700株-80.14%
2018/08/03日証協無担保0株0%0株0%900株-95.73%
2018/08/03日証協有担保189,948株+21.46%25,900株-57.48%43,800株+70.95%
2018/07/27日証協無担保0株0%0株-100%21,078株+1583.55%
2018/07/27日証協有担保156,385株+61.23%60,911株+1358.6%25,622株+1730.14%
2018/07/20日証協無担保0株0%524株0%1,252株-65.32%
2018/07/20日証協有担保96,992株-71.18%4,176株-68.61%1,400株-99.13%
2018/07/13日証協無担保0株0%0株0%3,610株+70.2%
2018/07/13日証協有担保336,565株-66.65%13,302株-77.18%161,800株-66.75%
2018/07/06日証協無担保0株0%0株-100%2,121株-57.58%
2018/07/06日証協有担保1,009,079株+1063.71%58,300株-23.8%486,621株+8010.35%
2018/06/29日証協無担保0株0%1,448株-90.78%5,000株-48.98%
2018/06/29日証協有担保86,712株-34.01%76,513株+833.09%6,000株-93.56%
2018/06/22日証協無担保0株-100%15,700株0%9,801株-93.33%
2018/06/22日証協有担保131,399株-3.11%8,200株-61.32%93,200株+2724.24%
2018/06/15日証協無担保49,300株+1197.37%0株0%147,024株+9701.6%
2018/06/15日証協有担保135,611株-24.44%21,200株-28.14%3,300株-86.42%
2018/06/08日証協無担保3,800株+322.22%0株0%1,500株+650%
2018/06/08日証協有担保179,481株-56.97%29,500株+135.83%24,300株-90.11%

※株式分割は考慮していませんのでご注意ください。

Page Top